Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...

President Trump pumped the brakes last week on a pledge to shut down an import tax exemption for cheap consumer goods from ...

Pinterest (NYSE:PINS – Free Report) had its target price upped by Cantor Fitzgerald from $36.00 to $48.00 in a research note ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...

Cantor Fitzgerald started coverage on shares of Science Applications International (NYSE:SAIC – Free Report) in a research ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...

Cantor Fitzgerald analyst Colin Canfield initiated coverage of Amentum (AMTM) with a Neutral rating and $25 price target Maximize Your ...

Cantor Fitzgerald analyst Thomas Blakey raised the firm’s price target on Cloudflare (NET) to $149 from $111 and keeps a Neutral rating on the ...